Bank Of America Corp Ambrx Biopharma Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.66 - $16.46 $3,477 - $7,472	454 Added 436.54%	558 $9,000
Q1 2023 May 12, 2023	BUY	$1.46 - $12.54 $5 - $50	4 Added 4.0%	104 $0
Q4 2022 Feb 10, 2023	SELL	$0.41 - $4.54 $0 - $4	-1 Reduced 0.99%	100 $0
Q2 2022 Aug 12, 2022	SELL	$2.53 - $4.35 $354 - $609	-140 Reduced 58.09%	101 $0
Q1 2022 May 16, 2022	BUY	$4.07 - $9.0 $447 - $990	110 Added 83.97%	241 $1,000
Q4 2021 Feb 08, 2022	BUY	$8.11 - $13.91 $243 - $417	30 Added 29.7%	131 $1,000
Q3 2021 Nov 15, 2021	SELL	$13.31 - $22.53 $119 - $202	-9 Reduced 8.18%	101 $1,000
Q2 2021 Sep 13, 2021	BUY	$15.95 - $19.6 $1,754 - $2,156	110 New	110 $2,000

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.